Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 3/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
| ▸ | PPARD | Q03181 | 1/20 | 0.31 |
| ▸ | MGAM | O43451 | 3/20 | 0.30 |
| ▸ | GAA | P10253 | 3/20 | 0.30 |
| ▸ | SI | P14410 | 3/20 | 0.30 |
| ▸ | MGAM2 | Q2M2H8 | 3/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18719623 | 0.89 | FFAR4 (0.32) | FFAR4FFAR1 | |
| SCHEMBL18735552 | 0.83 | CYP11B1 (0.32) | PPARD | |
| SCHEMBL19829154 | 0.81 | FFAR4 (0.33) | FFAR4PPARD | |
| SCHEMBL18735446 | 0.79 | RXRA (0.32) | FFAR4FFAR1PPARD | |
| SCHEMBL18735554 | 0.78 | AURKA (0.37) | FFAR4PPARD | |
| SCHEMBL18735549 | 0.76 | PDE2A (0.34) | FFAR4FFAR1PPARD | |
| SCHEMBL18719622 | 0.76 | MAOB (0.34) | — | |
| SCHEMBL4432399 | 0.75 | PTPN5 (0.34) | PPARD | |
| SCHEMBL17548018 | 0.75 | PTPN5 (0.34) | PPARD | |
| SCHEMBL12625491 | 0.75 | RARB (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9803140-B2 | Liquid crystal compound and liquid crystal composition | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO., LTD. (CN) | 2017-10-31 | — | — | US | disclosed |
| US-20170101581-A1 | LIQUID CRYSTAL COMPOUND AND LIQUID CRYSTAL COMPOSITION | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO., LTD. (CN) | 2017-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170101581-A1 | LIQUID CRYSTAL COMPOUND AND LIQUID CRYSTAL COMPOSITION | LBR, CTNND1, CCNT1 | FFAR4 1996/4885FFAR1 1000/4885PPARD 1406/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.